Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury. - Wikidata - awgldk - TriplyDB

Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.

Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.

http://www.wikidata.org/entity/Q35815261

about

The role of Nrf2: adipocyte differentiation, obesity, and insulin resistance Roles nrf2 plays in myeloid cells and related disorders Hepatic oxidative stress, genotoxicity and vascular dysfunction in lean or obese Zucker rats The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders The effect of oxidized phospholipids on phenotypic polarization and function of macrophages.Phenotypic polarization of macrophages in atherosclerosis Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics.Drug-Repositioning Screening for Keap1-Nrf2 Binding Inhibitors using Fluorescence Correlation Spectroscopy Oxidative stress as a crucial factor in liver diseases.Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis.Lipoicmethylenedioxyphenol Reduces Experimental Atherosclerosis through Activation of Nrf2 Signaling.Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis.Nrf2 and cardiovascular defense.The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome.Noninvasive mapping of the redox status of dimethylnitrosamine-induced hepatic fibrosis using in vivo dynamic nuclear polarization-magnetic resonance imaging.Oxidized Low-Density Lipoprotein Loading of Macrophages Downregulates TLR-Induced Proinflammatory Responses in a Gene-Specific and Temporal Manner through Transcriptional Control.The absence of macrophage Nrf2 promotes early atherogenesis.Oxidative Stress in Cardiovascular Diseases: Involvement of Nrf2 Antioxidant Redox Signaling in Macrophage Foam Cells Formation.Adipocyte adaptive immunity mediates diet-induced adipose inflammation and insulin resistance by decreasing adipose Treg cells.Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats.Activation of Nrf2 signaling by natural products-can it alleviate diabetes?Myeloid Cells and Chronic Liver Disease: a Comprehensive Review.

P2860

Q26825024-6AB17554-5478-4C5C-87AB-400446F1C84E Q27026726-934282F3-DE12-4BD7-9ADF-486C5745F175 Q28389287-E19E1EFB-0FD5-47A9-BABE-692967C72BCD Q28395641-3903EB28-6675-419F-AD74-1906B9A8F71A Q30268532-6CAD0941-9AAF-44EF-821C-72CDBBED786C Q30412717-78517A43-2964-47EA-A67B-9EBFD889633F Q33702016-A1E52410-C644-4A7F-88A1-1FC0265A5E3C Q33822548-723F251E-9FE7-493C-951A-1518965D6130 Q33845484-4A574120-FD47-4AAE-A0E8-DF73BEF32DBE Q34017968-12177918-EA4C-4A8A-B878-FFD0AA030AE7 Q35918474-A188EBAA-36D6-49EC-B29B-EA7F0288E557 Q38087926-8D1588E6-7585-42C0-B0A2-EEBC09E4893B Q38108306-3680E09D-0E16-4E08-A27D-AB24426B3539 Q38300447-64F2E0D7-8734-433F-BB5D-40235970869C Q40554348-4BBB96C7-2FC2-4D5E-B4F7-5F6A22A9A013 Q42513358-E51C43A8-8FA2-4A10-8214-2AE090B1DB98 Q43901244-4328B521-B891-4938-87DD-CAFFAA107D77 Q46266568-2291813F-C4BB-449F-82E7-A555E7355045 Q46311723-C726D3B7-1FD2-4512-8D55-B169C3D77A41 Q47113147-8B05E69C-0E8A-4AFD-B506-9E5A301DC92E Q49385295-96FAF338-2E32-4C36-94E2-F4FDDB63D5B0 Q50127735-9CD1003F-C54C-4D26-9913-E77A27216B64

P2860

Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.

http://www.wikidata.org/entity/Q35815261

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Myeloid deletion of nuclear fa ...... erosclerosis and liver injury.

@ast

Myeloid deletion of nuclear fa ...... erosclerosis and liver injury.

@en

type

label

Myeloid deletion of nuclear fa ...... erosclerosis and liver injury.

@ast

Myeloid deletion of nuclear fa ...... erosclerosis and liver injury.

@en

prefLabel

Myeloid deletion of nuclear fa ...... erosclerosis and liver injury.

@ast

Myeloid deletion of nuclear fa ...... erosclerosis and liver injury.

@en

P1433

Q35815261-3F7186E6-571A-45F1-8B56-7CCF09B89CB0

P1476

Q35815261-ED7B8484-CA83-4C32-AF4E-5C1E2C202846

P2093

Q35815261-0419B943-702E-45C5-B7EB-40A8E13086EC

Q35815261-17117639-707B-46E0-90BA-AAF5DD08D303

Q35815261-1E668B50-187E-4CE5-8C65-B59CACE872F8

Q35815261-2E18C319-20D0-4826-B282-2B43CA02EBDB

Q35815261-36D9B934-3C40-427F-85DA-F6A13BA93D78

Q35815261-4084F105-8968-46D3-8F5B-75E105BD73D0

Q35815261-4D522C8E-0831-498C-B446-20611CBA5677

Q35815261-6002F92A-A674-4237-8AAF-F4213B7BE0BA

Q35815261-9F9D6D36-EEE0-42D6-BCA3-3612B7B08E02

Q35815261-B3DE4281-EB61-435F-8E05-474B60A6A408

P2860

Q35815261-04018FCB-01F2-4CCB-8443-EBE6334006CD

Q35815261-055E61E1-8575-4114-813E-E65614C0A951

Q35815261-067301CA-F91A-48C9-8DC1-FE76E9DDD391

Q35815261-0D2AEE12-2BF6-421F-9E3F-771B2BDDB1D6

Q35815261-0D88E6D1-BEAF-44DC-BFCC-22AC69C372D9

Q35815261-0E82022C-7707-40CD-B294-C93F2AAE1BED

Q35815261-0FBB7F31-4342-4690-847D-143493435959

Q35815261-186B7BEE-E3E9-408C-9EA9-B1C111E9332D

Q35815261-24AB1947-250C-4D6C-BA9B-DDE4DEFA1331

Q35815261-252CA708-1AC2-4AF5-9E02-DD4917641893

P304

Q35815261-43F952A6-0017-4697-8B1C-083394ECB67D

P31

Q35815261-C72484EA-4A1C-41E2-BE27-E8F9028D5B1A

P356

Q35815261-312CEF36-20F0-4D71-B4A7-43D8D8848B0A

P407

Q35815261-2E4D665B-DA40-4395-87D5-8536E028BE4B

P433

Q35815261-052C3C6E-5381-4915-82CE-CC1344EE5A74

P478

Q35815261-20CB65EF-1AC0-4FFA-B7FE-31CD62255CD6

P50

Q35815261-25B017FE-D55B-4D07-AD3D-928B90BDE0EC

P577

Q35815261-46A1B213-C8D2-453A-92BB-80A366107881

P698

Q35815261-23F8091E-D686-463C-8A79-64777E0330B9

P921

Q35815261-8EAA416A-0CA7-4DF6-9AA2-EF0226781AAB

P932

Q35815261-3F5153FA-6F65-4135-98B4-8F8CAB45A3B6

P356

ATVBAHA.112.300345

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Myeloid deletion of nuclear fa ...... erosclerosis and liver injury.

@en

P2093

Alan R Collins

http://www.w3.org/2001/XMLSchema#string

Christopher J Lyon

http://www.w3.org/2001/XMLSchema#string

Joey Z Liu

http://www.w3.org/2001/XMLSchema#string

Jun Wang

http://www.w3.org/2001/XMLSchema#string

Laurie J Minze

http://www.w3.org/2001/XMLSchema#string

Magda Arredondo

http://www.w3.org/2001/XMLSchema#string

Maricela R Ramirez

http://www.w3.org/2001/XMLSchema#string

Ruirui Ji

http://www.w3.org/2001/XMLSchema#string

Tuo Deng

http://www.w3.org/2001/XMLSchema#string

Willa A Hsueh

http://www.w3.org/2001/XMLSchema#string

P2860

Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II

NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection

Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of NRF2-mediated antioxidant response

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

Nrf2 deficiency in myeloid cells is not sufficient to protect mice from high-fat diet-induced adipose tissue inflammation and insulin resistance.

Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo.

Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP.

Overexpression of catalase in myeloid cells causes impaired postischemic neovascularization.

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.

P304

2839-2846

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.112.300345

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Anisha A. Gupte

P577

2012-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23023374

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4490864

http://www.w3.org/2001/XMLSchema#string